Skip to content

Effects of Neurostimulation in children with speech and language difficulties

Transcranial Direct Current Stimulation in cognitive and language skills

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-67fdcbg
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Language Disorders

Interventions

This is a randomized, placebo-controlled, double-blind, crossover clinical study to be conducted on children aged 6 to 12 years with speech and language disorders who will undergo Transcranial Direct

Sponsors

Universidade Federal de Sergipe
Lead Sponsor
Programa de Pós-graduação em ciências aplicadas à Saúde (PPGCAS)
Collaborator

Eligibility

Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Children of any sex; have a diagnosis of speech and language disorders; aged between 6 and 12 years old; inserted in the regular school environment; have degrees of understanding and collaboration compatible with carrying out the proposed intervention, that is, accept the placement of electrodes and the time required for stimulation

Exclusion criteria

Exclusion criteria: Children whose guardians, at some point during the research, withdraw their free and informed consent; children with epilepsy; who use metallic brain implants or hearing aids

Design outcomes

Primary

MeasureTime frame
It is expected that anodal transcranial direct current stimulation associated with speech therapy intervention can optimize the therapeutic process in the rehabilitation of cognitive and language disorders

Secondary

MeasureTime frame
Verify whether the effects obtained last in the long term (3-month follow-up) after the intervention

Countries

Brazil

Contacts

Public ContactMaria Vanessa Alves

Universidade Federal de Sergipe

vanessamartins_fono@outlook.com+55 (79) 3194-6805

Outcome results

None listed

Source: REBEC (via WHO ICTRP)